Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT07219576
Recruiting
Retifanlimab and Ruxolitinib In Solid Malignancies
Phase 1/2 · United States · 1 site
Registry update: 13 Jan 2026
NCT07195916
Recruiting
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Phase 1 · Australia, Belgium, Denmark, Italy, United States · 22 sites
Registry update: 9 Oct 2026
NCT07239596
Recruiting
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
Phase 1/2 · China · 1 site
Registry update: 11 Aug 2026
NCT07299357
Recruiting
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
Not applicable · Italy · 2 sites
Registry update: 21 Jan 2026
NCT06730672
Recruiting
An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
Phase 2 · China · 2 sites
Registry update: 22 Oct 2026
NCT07148050
Recruiting
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Phase 1 · United States · 1 site
Registry update: 17 Feb 2026
NCT07300241
Recruiting
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 16 sites
Registry update: 4 Nov 2026
NCT07187778
Recruiting
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
Phase 2 · United States · 2 sites
Registry update: 9 Nov 2026
NCT07285044
Recruiting
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 · United States · 1 site
Registry update: 30 Sept 2026
NCT07369505
Recruiting
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · Australia · 1 site
Registry update: 27 Jan 2026
NCT07485114
Recruiting
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Not applicable · Israel · 1 site
Registry update: 20 Mar 2026
NCT07073703
Recruiting
Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.
Not applicable · France · 2 sites
Registry update: 9 Dec 2025
NCT07292168
Recruiting
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Phase 1/2 · Russia · 5 sites
Registry update: 10 Nov 2026
NCT06138067
Recruiting
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Not applicable · United States · 2 sites
Registry update: 3 Sept 2026
NCT07227402
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Chile, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hong Kong, Croatia, Ireland, Italy, South Korea, Mexico, Poland, Saudi Arabia, Singapore, Taiwan, United States · 134 sites
Registry update: 12 Nov 2026
NCT07123090
Recruiting
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Phase 2 · United States · 2 sites
Registry update: 20 Aug 2026
NCT07389629
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 · China · 1 site
Registry update: 5 Feb 2026
NCT07023432
Recruiting
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
Phase 2 · United States · 1 site
Registry update: 12 Nov 2026
NCT07092566
Recruiting
R.E.C.K vs Exparel in Robotic Nephrectomy
Phase 3 · United States · 1 site
Registry update: 13 Jul 2026
NCT07244835
Recruiting
A Study of DEG6498 in Participants With Solid Tumors
Phase 1 · China · 3 sites
Registry update: 30 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.